Carna Biosciences Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Revenue	572	636	1,625	1,386	2,017	1,133	Upgrade
Revenue Growth (YoY)	-60.28%	-60.86%	17.24%	-31.28%	78.02%	-64.67%	Upgrade
Cost of Revenue	166	171	175	171	135	192	Upgrade
Gross Profit	406	465	1,450	1,215	1,882	941	Upgrade
Selling, General & Admin	553	655	664	603	572	524	Upgrade
Research & Development	1,886	1,886	1,903	1,882	1,841	1,474	Upgrade
Operating Expenses	2,439	2,541	2,567	2,485	2,413	1,998	Upgrade
Operating Income	-2,033	-2,076	-1,117	-1,270	-531	-1,057	Upgrade
Interest Expense	-3	-3	-4	-6	-4	-7	Upgrade
Interest & Investment Income	16	14	-	-	-	-	Upgrade
Currency Exchange Gain (Loss)	-6	26	-	-	14	-9	Upgrade
Other Non Operating Income (Expenses)	-23	-42	-5	-3	-3	-5	Upgrade
EBT Excluding Unusual Items	-2,049	-2,081	-1,126	-1,279	-524	-1,078	Upgrade
Asset Writedown	-89	-93	-4	-44	-9	-26	Upgrade
Other Unusual Items	-	-	-	-	-	1	Upgrade
Pretax Income	-2,138	-2,174	-1,130	-1,323	-533	-1,103	Upgrade
Income Tax Expense	2	4	22	26	1	8	Upgrade
Net Income	-2,140	-2,178	-1,152	-1,349	-534	-1,111	Upgrade
Net Income to Common	-2,140	-2,178	-1,152	-1,349	-534	-1,111	Upgrade
Shares Outstanding (Basic)	19	18	17	14	13	12	Upgrade
Shares Outstanding (Diluted)	19	18	17	14	13	12	Upgrade
Shares Change (YoY)	9.23%	6.61%	23.37%	7.26%	3.22%	10.64%	Upgrade
EPS (Basic)	-113.77	-121.61	-68.57	-99.06	-42.06	-90.33	Upgrade
EPS (Diluted)	-113.77	-121.61	-68.57	-99.06	-42.06	-90.33	Upgrade
Free Cash Flow	-2,152	-1,387	-1,688	-834	-1,577	-1,324	Upgrade
Free Cash Flow Per Share	-114.41	-77.44	-100.48	-61.24	-124.22	-107.65	Upgrade
Gross Margin	70.98%	73.11%	89.23%	87.66%	93.31%	83.05%	Upgrade
Operating Margin	-355.42%	-326.41%	-68.74%	-91.63%	-26.33%	-93.29%	Upgrade
Profit Margin	-374.13%	-342.45%	-70.89%	-97.33%	-26.47%	-98.06%	Upgrade
Free Cash Flow Margin	-376.22%	-218.08%	-103.88%	-60.17%	-78.19%	-116.86%	Upgrade
EBITDA	-2,002	-2,045	-1,082	-1,237	-512	-1,045	Upgrade
EBITDA Margin	-	-	-66.59%	-89.25%	-25.38%	-92.23%	Upgrade
D&A For EBITDA	31.5	31	35	33	19	12	Upgrade
EBIT	-2,033	-2,076	-1,117	-1,270	-531	-1,057	Upgrade
EBIT Margin	-	-	-68.74%	-91.63%	-26.33%	-93.29%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.